Cargando…

Remyelination Induced by a DNA Aptamer in a Mouse Model of Multiple Sclerosis

Multiple sclerosis (MS) is a debilitating inflammatory disease of the central nervous system (CNS) characterized by local destruction of the insulating myelin surrounding neuronal axons. With more than 200 million MS patients worldwide, the absence of treatments that prevent progression or induce re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nastasijevic, Branislav, Wright, Brent R., Smestad, John, Warrington, Arthur E., Rodriguez, Moses, Maher, L. James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384608/ https://www.ncbi.nlm.nih.gov/pubmed/22761835 http://dx.doi.org/10.1371/journal.pone.0039595

Ejemplares similares

An Assay that Predicts In Vivo Efficacy for DNA Aptamers that Stimulate Remyelination in a Mouse Model of Multiple Sclerosis
por: Heider, Robin M., et al.
Publicado: (2018)

Ion-dependent conformational switching by a DNA aptamer that induces remyelination in a mouse model of multiple sclerosis
por: Smestad, John, et al.
Publicado: (2013)

Optimization of a 40-mer Antimyelin DNA Aptamer Identifies a 20-mer with Enhanced Properties for Potential Multiple Sclerosis Therapy
por: Wilbanks, Brandon, et al.
Publicado: (2019)

Remyelination-Promoting DNA Aptamer Conjugate Myaptavin-3064 Binds to Adult Oligodendrocytes In Vitro
por: Fereidan-Esfahani, Mahboubeh, et al.
Publicado: (2020)

Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice
por: Perschbacher, Katherine, et al.
Publicado: (2015)

Remyelination In Multiple Sclerosis
por: Chari, Divya M.
Publicado: (2007)

A monoclonal natural human IgM protects axons in the absence of remyelination
por: Wootla, Bharath, et al.
Publicado: (2016)

PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation
por: Watzlawik, Jens O., et al.
Publicado: (2013)

Remyelination Therapy in Multiple Sclerosis
por: Harlow, Danielle E., et al.
Publicado: (2015)

Promoting remyelination in multiple sclerosis
por: Cunniffe, Nick, et al.
Publicado: (2019)

Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease
por: Wootla, Bharath, et al.
Publicado: (2015)

Remyelination Improves Voiding Dysfunction in a Mouse Model of Multiple Sclerosis
por: Ramasamy, Ramalakshmi, et al.
Publicado: (2021)

Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination
por: Podbielska, Maria, et al.
Publicado: (2013)

Remyelination therapy goes to trial for multiple sclerosis
por: Brugarolas, Pedro, et al.
Publicado: (2014)

Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Jolanda Münzel, E., et al.
Publicado: (2013)

Imaging outcomes for trials of remyelination in multiple sclerosis
por: Mallik, Shahrukh, et al.
Publicado: (2014)

The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis
por: You, Yuyi, et al.
Publicado: (2018)

The Molecular Basis for Remyelination Failure in Multiple Sclerosis
por: Gruchot, Joel, et al.
Publicado: (2019)

Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination
por: Correale, Jorge, et al.
Publicado: (2022)

Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model
por: Leo, Heinig, et al.
Publicado: (2022)

Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis
por: Zhao, Xinda, et al.
Publicado: (2023)

Remyelination as Neuroprotection
por: Howe, Charles L., et al.
Publicado: (2005)

Multiple Sclerosis: Mechanisms of Disease and Strategies for Myelin and Axonal Repair
por: Lemus, Hernan Nicolas, et al.
Publicado: (2018)

Neuronal gene transcription modulates demyelination and remyelination in a mouse model of multiple sclerosis
por: Anastasiadou, Sofia, et al.
Publicado: (2015)

Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis
por: Dupree, Jeffrey L., et al.
Publicado: (2022)

Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis
por: Brown, Robert A., et al.
Publicado: (2014)

Erratum to: Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Münzel, E. Jolanda, et al.
Publicado: (2013)

Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis
por: Bodini, Benedetta, et al.
Publicado: (2016)

Remyelination in multiple sclerosis from the miRNA perspective
por: Maciak, Karina, et al.
Publicado: (2023)

Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis
por: Dasari, Harika, et al.
Publicado: (2016)

Correlated Heterospectral Lipidomics for Biomolecular Profiling of Remyelination in Multiple Sclerosis
por: Bergholt, Mads S., et al.
Publicado: (2017)

Dietary Supplementation With Acer truncatum Oil Promotes Remyelination in a Mouse Model of Multiple Sclerosis
por: Xue, Yuhuan, et al.
Publicado: (2022)

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
por: Al Nimer, Faiez, et al.
Publicado: (2016)

Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis
por: Gharagozloo, Marjan, et al.
Publicado: (2022)

Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis
por: Karim, Hawra, et al.
Publicado: (2019)

Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis
por: Sekyi, Maria T., et al.
Publicado: (2021)

Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination
por: Schultz, Verena, et al.
Publicado: (2017)

The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis
por: Ben-Shalom, Ido, et al.
Publicado: (2021)

Remyelination varies between and within lesions in multiple sclerosis following bexarotene
por: Brown, J. William L., et al.
Publicado: (2022)

7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions
por: Kolb, Hadar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tocqo20lm55kk517c6v9cavjtu